New Universal Influenza Vaccine in Development
December 4th 2019In partnership with a team of medical centers, universities, and private industries, Emmes, a scientific research company, will support the development of a “universal influenza vaccine†that could provide longer-lasting protection than the current vaccines available, according to a company press release. The vaccine would also combat a wider variety of influenza viruses.
Setting the Record Straight During National Influenza Vaccination Week
December 3rd 2019Since 2005, the CDC has enforced National Influenza Vaccination Week to emphasize the importance of continuing flu vaccination even through the winter months. Although it is the holiday season, the CDC and other organizations want to remind the general public that it is never a bad time to get your flu vaccine. Sam Nass, PharmD, MBS and Walgreens Immunizations Manager weighed in on the subject in an interview with Pharmacy Times®.
Dapagliflozin: Benefits in Heart Failure Patients With and Without Diabetes
December 2nd 2019A study published in September 2019 in the New England Journal of Medicine has found that patients HF with reduced ejection fraction (HFrEF) receiving dapagliflozin decreased their risk of worsening HF or death from cardiovascular causes.
Midazolam Nasal Spray Available in Retail Pharmacies Starting in December
November 25th 2019Starting December 2, midazolam (Nayzilam, UCB) will be available at retail pharmacies for the acute treatment of intermittent, stereotypic episodes of frequent seizure activity that are distinct from a patient’s usual seizure pattern with epilepsy.
Tafenoquine Tablets Now Available in US as First Prescription Drug for Malaria Prevention
November 21st 2019Tafenoquine (Arakoda), the first prescription drug approved for the prevention of malaria in adults, is now available in the United States, according to a press release. Tafenoquine has the potential to protect thousands of US travelers and military personnel from the effects of malaria.
FDA Approves Contact Lenses to Slow Progression of Myopia in Children
November 19th 2019Officials from the FDA have approved MiSight 1-day contact lenses (CooperVision), a daily wear, single use contact lens indicated for the use of myopia management. This is the first and only FDA-approved product clinically proven to slow the progression of myopia, or near-sightedness, when initially prescribed for children 8-12 years old.
Study Finds Melanoma Rates Drop Sharply Among Teens and Young Adults
November 14th 2019According to a study published by JAMA Dermatology, cases of melanoma in the United States among adolescents and young adults has declined from 2006-2015, suggesting that public-health efforts advocating sun protection are changing behaviors among the younger generations.
Study: The Efficiency of Intranasal Versus Intramuscular Naloxone for Opioid Overdose
November 12th 2019A study conducted by the Uniting Medically Supervised Injecting Centre in Sydney, Australia found that intranasally administered naloxone can reverse opioid overdose, but not as efficiently as intramuscularly administered naloxone can.
Nurse Practitioners: An Integral Role to Healthcare Facilities
November 8th 2019NPs are able to work in a variety of healthcare settings, such as a hospital, physician’s office, or a clinic. Their functions include diagnosing patients, performing physical exams, dispensing medications to patients and more. Unlike a registered nurse (RN), NPs are able to hold decision-making authority similar to a physician.
CDC: Adverse Childhood Events Linked to Chronic Health Conditions in Adulthood
November 7th 2019Although adverse childhood events have been linked to leading causes of adult morbidity and mortality in many studies over recent decades, the Centers for Disease Control and Prevention (CDC) has released a new analysis of childhood experiences and their effect on adult outcomes.
17% of Food-Allergic Children Have Sesame Allergy, NIH Study Shows
November 4th 2019Sesame allergy is common among children with other food allergies, occurring in an estimated 17% of the population, according to researchers at the NIH. In addition, the study found that sesame antibody testing accurately predicts whether a child with food allergy is allergic to sesame.
Study Suggests Acetaminophen Exposure in Pregnancy Linked to Higher Risk of ADHD, Autism
October 30th 2019Researchers at the National Institutes of Health and the Agency for Health Care Research and Quality have found that exposure to acetaminophen in the womb may increase a child’s risk for attention deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD).
"Let Me Be Clear" Campaign Launched to Empower People with Psoriasis
October 29th 2019An empowerment platform for people living with psoriasis, Let Me Be Clear, was launched by pharmaceutical company, AbbVie. The campaign invites people living with psoriasis to share their story, access tools to have informed conversations with their physicians, and discuss what freedom from psoriasis would mean to them.